Login / Signup

ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug Discovery.

Albert BouMorgan ThomasSebastian DittertCarles NavarroMaciej MajewskiYe WangShivam PatelGary John TresadernMazen AhmadVincent MoensWoody ShermanSimone SciabolaGianni De Fabritiis
Published in: Journal of chemical information and modeling (2024)
In recent years, reinforcement learning (RL) has emerged as a valuable tool in drug design, offering the potential to propose and optimize molecules with desired properties. However, striking a balance between capabilities, flexibility, reliability, and efficiency remains challenging due to the complexity of advanced RL algorithms and the significant reliance on specialized code. In this work, we introduce ACEGEN, a comprehensive and streamlined toolkit tailored for generative drug design, built using TorchRL, a modern RL library that offers thoroughly tested reusable components. We validate ACEGEN by benchmarking against other published generative modeling algorithms and show comparable or improved performance. We also show examples of ACEGEN applied in multiple drug discovery case studies. ACEGEN is accessible at https://github.com/acellera/acegen-open and available for use under the MIT license.
Keyphrases
  • drug discovery
  • machine learning
  • deep learning
  • minimally invasive
  • adverse drug
  • drug induced
  • smoking cessation
  • randomized controlled trial
  • meta analyses